Drug profile · INN
methyl aminolevulinate hydrochloride
METVIXIA
methyl aminolevulinate hydrochloride (METVIXIA) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — methyl aminolevulinate hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methyl aminolevulinate hydrochloride (METVIXIA) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methyl aminolevulinate hydrochloride?
methyl aminolevulinate hydrochloride (METVIXIA) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for methyl aminolevulinate hydrochloride?
METVIXIA is a marketed brand name for methyl aminolevulinate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methyl aminolevulinate hydrochloride?
methyl aminolevulinate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.